Adipose tissue-derived extracellular vesicles from obese mice suppressed splenocyte-mediated pancreatic cancer cell death
Open Access
- 3 October 2024
- journal article
- research article
- Published by SNF Swedish Nutrition Foundation in Food & Nutrition Research
- Vol. 68
Abstract
Background: Obesity is a risk factor for pancreatic cancer and negatively contributes to the immune system. However, the mechanisms by which obesity mediates these actions are still poorly understood. Recent studies have demonstrated that extracellular vesicles (EVs) are key mediators of communication between cells and may influence various aspects of cancer progression. Objectives: We aim to explore the influence of EVs derived from adipose tissue of obese mice on cytokine production within the interactions between cancer cells and immune cells. Design: We isolated EVs from the adipose tissue of both C57BL6/J mice and Ob/Ob mice. Subsequently, we treated EVs with Panc02 cells, the murine ductal pancreatic cancer cell line, which were co-cultured with splenocytes. Viability and SMAD4 gene expression were examined in Panc02 cells, and cytokine concentrations of IL-6, IL-4, IL-12, and IL-12p70 were measured in the cultured medium. Results: Interestingly, we observed a significant reduction in splenocyte-mediated Panc02 cell death when treated with EVs derived from the adipose tissue of Ob/Ob mice, compared to those from C57BL6/J mice. Additionally, EVs from Ob/Ob mice-derived adipose tissue significantly increased the levels of IL-4, IL-2, and IL-12p70 in the culture media of Panc02 cells co-cultured with splenocytes, compared to EVs from C57BL6/J mice-derived adipose tissue. Conclusion: Adipose tissue-derived EVs from obese mice suppressed splenocyte-mediated Panc02 cell death and upregulated IL-4, IL-2, and IL-12p70 in cultured medium.Keywords
This publication has 37 references indexed in Scilit:
- Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosisCancer Letters, 2021
- Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerCell Reports, 2021
- Adipose tissue and insulin resistance in obeseBiomedicine & Pharmacotherapy, 2021
- Therapeutic targeting with DABIL‐4 depletes myeloid suppressor cells in 4T1 triple‐negative breast cancer modelMolecular Oncology, 2021
- Association of Obesity With Survival Outcomes in Patients With CancerJAMA Network Open, 2021
- FGF21 in obesity and cancer: New insightsCancer Letters, 2021
- Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axisJournal of Physiology and Biochemistry, 2019
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of MetastasisCancer Cell, 2016
- Tumor-induced perturbations of cytokines and immune cell networksBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Overview of interleukin-2 function, production and clinical applicationsCytokine, 2004